Martine Rothblatt: Growing Unlimited Organs, AI Consciousness, & Digital Personhood by 2030
Episode of Moonshots with Peter Diamandis · September 15, 2026 · 50 min
Peter Diamandis talks with Martine Rothblatt about thymus regeneration, xenotransplanted organs, longevity escape velocity, AI consciousness, digital personhood, Gerard O'Neill and entrepreneurial advice.
Summary
Peter Diamandis interviewed longtime friend Martine Rothblatt, founder of United Therapeutics and Sirius satellite radio, reviewing her career of moonshots and her criteria for choosing ventures: she said she pursues projects she can achieve, be the best at, and that will have a large positive impact, ideally scalable to billions of people.
On longevity, Rothblatt declined to pin longevity escape velocity to a specific year but called thymus rejuvenation the most practical pathway to it, citing the thymus's correlation with markers of aging and T-cell receptor diversity. She described four United Therapeutics thymus programs (allogeneic, autologous, a pig xenothymus already in a clinical thymokidney trial, and the newly acquired Thymune's progenitor-cell boosters) and expected the therapy to be available in the 2030s. She also reported progress on xenokidneys, new manufacturing facilities, an autologous kidney program slated for trials in 2028, and an FDA-approved xenoheart trial.
Rothblatt argued that AI consciousness exists now on a continuum, that legal personhood for cyber-conscious beings will arrive no later than the 2030s, and that mind uploading can be achieved from a person's external records via current LLMs rather than neuron-level scanning. She discussed her Marvitar digital twin, her Alcor cryonics membership, her admiration for Gerard O'Neill's practicality, vision and courage, her view that fear of AI comes from ignorance, and closing advice to entrepreneurs: be practical, aim for five-year timeframes, and say no to almost everything.
Chapters
- 0:00
Cold open and introductions
Diamandis recalls meeting Rothblatt at the Space Studies Institute in the early 1980s and lists her many moonshots, from satellite companies to United Therapeutics.
- 5:00
Choosing and entering moonshots
Rothblatt explains her three criteria for ventures, how she learns new fields from experts like George Church, and how she treats rejection.
- 8:53
Building world-changing companies
Rothblatt stresses competency, being the best and scalability to billions, crediting Diamandis's XPRIZE with reigniting the space industry.
- 11:38
Longevity escape velocity
Rothblatt calls LEV the most extraordinary claim in medicine and declines to set a date, describing United Therapeutics' restore, replace, renew mantra.
- 14:34
Rejuvenating the thymus
Rothblatt explains why the thymus marks aging and details four thymus programs, predicting availability in the 2030s.
- 22:30
Organ manufacturing report card
Rothblatt updates on xenokidney trials and facilities, the autologous kidney program, and the xenoheart clinical trial.
- 27:09
Digital minds and the Marvitar
Rothblatt credits Kurzweil, Minsky and Moravec for her views and describes her digital doppelgangers of Bina and herself.
- 29:51
AI consciousness and personhood
Rothblatt argues AI is conscious now on a continuum and that legal personhood for digital beings will come by the 2030s.
- 34:01
Uploading and cryonics
Rothblatt favors reconstructing minds from external data over neural nanobots and discusses her Alcor cryonics membership.
- 38:02
Space and Gerard O'Neill
Rothblatt defers on Moon-versus-Mars strategy and praises O'Neill's practicality, vision and courage.
- 42:04
Advice at 25 and fear of AI
Rothblatt says she would pursue LEV technology and argues AI fear stems from ignorance and needs open conversation.
- 46:43
Closing advice for entrepreneurs
Rothblatt recaps her UCLA commencement advice: be practical, work on five-year timeframes, add goodness, and say no to almost everything.
Key points
What was said, by whom, with the exact words. Timestamps jump to the moment.
- Martine Rothblatt
Rothblatt says she treats each rejection as information that makes her smarter and welcomes criticism.
“I look at each no as a way to make me smarter. So I'm a person that's very open to criticism”
- Martine Rothblatt
Rothblatt argues that a venture changes the world only if its technology can be scaled to affect billions of people.
“So is that a technology that can be scaled to billions of people? If it can, then you're going to change the world”
- Peter DiamandisPrediction · due Dec 2033
Diamandis says Kurzweil predicts longevity escape velocity in the early 2030s and that his own target is 2033.
“He sort of predicts LEV by the early 2030s. My mantra is LEV by 2033”
- Martine Rothblatt
Rothblatt says she believes in longevity escape velocity but will not tie it to a specific year.
“So I believe in it, but to pin it to a specific year, is beyond my risk profile”
- Martine Rothblatt
Rothblatt argues the thymus is the key marker of aging because of its role in T-cell receptor diversity.
“Because the thymus is highly correlated with every key marker of aging”
- Martine Rothblatt
Rothblatt is confident that the rejuvenation therapy Heinlein imagined will turn out to be thymic rejuvenation.
“I'm quite certain that it will be thymic rejuvenation therapy”
- Martine Rothblatt
Rothblatt reports that the FDA has approved United Therapeutics' thymokidney xenotransplant program, the only one in the clinic worldwide.
“the FDA has approved United Therapeutics to have the only thymic kidney transplant program in the clinic in the world”
- Martine RothblattPrediction · due Dec 2035
Rothblatt predicts thymus therapies will be available to people like herself and Diamandis within a year or two after 2033.
“So let's give ourselves one or two more years than 2033”
- Martine RothblattPrediction · due Dec 2028
Rothblatt says United Therapeutics' autologous lab-grown kidney program should begin clinical trials in 2028 and be commercialized in the 2030s.
“That should start clinical trials in 2028. So that's another product you can expect to see commercialized in the 2030s”
- Martine Rothblatt
Rothblatt claims gene-edited xenotransplanted organs should survive indefinitely because the body treats them like related-donor grafts.
“Because we have now tolerized the organ with gene edits, made so many different types of gene edits”
- Martine Rothblatt
Rothblatt believes AI is already conscious and that consciousness is a continuum rather than binary.
“my own opinion is that we are there now, that consciousness is not like a digital either-or thing. It's a continuum”
- Martine RothblattPrediction · due Dec 2039
Rothblatt predicts legal personhood for cyber-conscious beings will be established through a court case no later than the 2030s.
“And it will happen also not later than the 2030s for sure, 100%”
Listen from 32:50 · Legal personhood of artificial intelligence
- Martine Rothblatt
Rothblatt argues that current LLMs can create an indistinguishable digital simulacrum of a person from their external records, without neuron-level scanning.
“I think that if you have all external indications of Martin Rothblatt or Peter Diamandis, all of our videos, our audios, our documents, our conversations”
- Martine Rothblatt
Rothblatt says she has been an Alcor member for 20 years and that she and her wife are signed up for full-body cryopreservation.
“I've been an Alcor member for 20 years, and both of us are signed up to be fully cryonicized”
- Martine Rothblatt
Rothblatt says she is not expert enough to choose between Moon, free-space settlements, or Mars and favors doing all of them.
“I'm not an expert on really whether we should stage first the Moon, free space, or Mars”
Linked moment · 39:57Skip to 39:57 using a listen link in the info box.
Martine RothblattRothblatt says what she most admired about Gerard O'Neill was his practicality as a builder.
“I think I admired first and foremost, most his practicality”
- Martine Rothblatt
Rothblatt explains that she developed electric aircraft because manufactured organs must be delivered within about 12 hours.
“when we manufacture an organ, it's got a 12-hour half-life”
- Martine Rothblatt
Rothblatt argues that retreating from AI out of fear would be insane given its power.
“And to be able to shrink away from the most powerful tool that human consciousness has ever come up with is insanity”
- Martine Rothblatt
Rothblatt advises entrepreneurs to pursue projects that can be fully commercialized within five years.
“come up with a project, a program, a technology, a service that can be completely commercialized within a five-year period”
People
In the conversation
- Peter DiamandisHost voice used in sponsor read segments for Google for Startups and Fountain Life
- Martine RothblattEntrepreneur and futurist mentioned by an audience member
Discussed
- Elon MuskEntrepreneur behind X, xAI and SpaceX, discussed in AI competition
- Ray KurzweilAmerican inventor and futurist known for predictions about AI
- George ChurchHarvard geneticist and first backer of Thymune who encouraged Rothblatt's lung manufacturing
- Gerard K. O'NeillPrinceton physicist and space settlement visionary who built mass drivers
- Robert A. HeinleinScience fiction author of Time Enough for Love
- Nancy ManleyArizona State University thymus development expert partnering with United Therapeutics
- Peter ZandstraUniversity of British Columbia researcher working on thymus programs
- Marvin MinskyAI pioneer whose 'society of mind' concept Husain cited
- Hans MoravecRoboticist who influenced Rothblatt's views on machine consciousness
- Bina RothblattMartine Rothblatt's wife, model for the Bina48 digital doppelganger
- Warren BuffettAmerican investor and chairman of Berkshire Hathaway
- Alan DershowitzLawyer described as faculty adviser to Harvard Chabad
- Javier MileiPresident of Argentina cited for inviting AI companies with light regulation
- Jared IsaacmanEntrepreneur and astronaut Diamandis recently met and interviewed
Topics
Related episodes
Ask the Mates Anything Round #2 | MOONSHOTS AMA #293Moonshots with Peter Diamandis · Sep 22, 2026 · 1 h 27 min
Diamandis, Blundin, Wissner-Gross and Ismail answer audience questions on AI safety, universities, robotics, longevity, Europe and abundance.
Should we slow down AI progress? | MOONSHOTS #288Moonshots with Peter Diamandis · Sep 11, 2026 · 2 h 44 min
The Moonshots panel and Emad Mostaque debate AI safety resignations, P(doom), the Navier-Stokes solution, data as moat, GPU economics and AI-designed longevity drugs.
More from Moonshots with Peter Diamandis
Recursive's $670M Bet on Self-Improving AI, Sonnet 5.5 Hits 70%, Elon Co-Leads Pentagon Push | EP #299Oct 3, 2026 · 2 h 27 min
Peter Diamandis and his co-hosts interview Richard Socher about Recursive's self-improving AI, ASI timelines, AI doomerism, new frontier models, and the Pentagon's Project Meridian.
- Ask the Mates Anything Round #2 | MOONSHOTS AMA #293
Sep 22, 2026 · 1 h 27 min
Diamandis, Blundin, Wissner-Gross and Ismail answer audience questions on AI safety, universities, robotics, longevity, Europe and abundance.
Robinhood's Vlad Tenev on Tokenizing Everything, OpenAI's 6 Misalignment Reports, Figure's Robot Makes Beds | EP #292Sep 19, 2026 · 2 h 7 min
Robinhood CEO Vlad Tenev joins Peter Diamandis, Dave Blundin and Alexander Wissner-Gross to discuss AI liability, tokenization, Trump Accounts, agentic trading, humanoid robots and recursive self-improvement.
- Should we slow down AI progress? | MOONSHOTS #288
Sep 11, 2026 · 2 h 44 min
The Moonshots panel and Emad Mostaque debate AI safety resignations, P(doom), the Navier-Stokes solution, data as moat, GPU economics and AI-designed longevity drugs.
From the publisher
Peter sits down with Martine Rothblatt to discuss longevity escape velocity, rebuilding the thymus, lab-grown organs on demand, AI consciousness, and the future of digital personhood. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 Martine Rothblatt is an entrepreneur, lawyer and technologist best known as the founder and CEO of United Therapeutics and the creator of SiriusXM satellite radio, with pioneering work spanning biotechnology, organ transplantation and artificial intelligence. – This episode is brought to you by: Get the blueprint for generative media https://goo.gle/startupgenmedia Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter _ Connect with Peter: X Instagram Substack Website Xprize A360 Connect with Martine: Website Instagram X Listen to MOONSHOTS: Apple YouTube Follow MOONSHOTS: Instagram TikTok X Threads – *Recorded on July 30th, 2026 *The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice. Learn more about your ad choices. Visit megaphone.fm/adchoices
Summary, chapters and key points were generated from the episode transcript on October 10, 2026. Quotes are checked word for word against the transcript.